Get the Stockscreener App
0.5817
8.57%
-0.0683
Organovo Holdings Inc Stock (ONVO) Latest News
Organovo (NASDAQ:ONVO) Coverage Initiated by Analysts at StockNews.com - Defense World
Top Biotech Stocks To Follow TodayFebruary 25th - MarketBeat
Human Organoids Market Research Report 2025 | Now AvailableGlobal Forecasts to 2030 - GlobeNewswire
Is Eli Lilly Stock Outperforming the Nasdaq? - TradingView
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) previously treated with a BTK inhibitor - Quantisnow
3d Printing For Medical Sector Market Generated Opportunities, - openPR
Investor Network: Organovo Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Global Human Liver Model Market 2025-2030: Growth Driven by 3D Bioprinting & Liver Disease Research - GlobeNewswire Inc.
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.43% - Investing.com
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.43% - Investing.com UK
WWE Revenue Dip Amid ‘Raw’ Shift To Netflix Squeezes Endeavor-Run TKO’s Q4 Results, But Numbers Still Top Wall Street Forecasts - Yahoo Finance UK
Promising Small Cap Stocks To Follow NowFebruary 25th - MarketBeat
Large owner Lilly Endowment Inc sold $203,190,794 worth of shares (225,000 units at $903.07), decreasing direct ownership by 0.23% to 96,236,978 units (SEC Form 4) - Quantisnow
G20 leaders warn declining cooperation threat to global stability - Yahoo Finance UK
Keir Starmer’s defence pledge will prompt ‘tough choices’ on tax - Yahoo Finance UK
Small-Caps Under $2 on the Move: ENVB, ONVO, TRNR, PRSO, PNPN.V Gaining Momentum - openPR
Shadow Chancellor slams inheritance tax changes as an “absurdity” - Yahoo Finance UK
Eli Lilly and Company entered into an asset purchase agreement to acquire FXR Program and Related Assets of Organovo Holdings, Inc. for $60 million. - Marketscreener.com
Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion - Quantisnow
Record year for UniCredit bank sees top banker's pay rise by a third - Yahoo
IGA seeks garage owners’ input ahead of key MOT fee meeting - Yahoo News
Indonesia agrees deal with Apple that could end iPhone sales ban - Yahoo Finance UK
Australian Vintage unveils new wine range amid mixed half-year results - Yahoo
Hong Kong pledges $127.67 million to create AI institute - Yahoo
BP unveils multi-billion-dollar deal to redevelop Iraq's oil fields - Yahoo
Stellantis says 2024 profits fall 70% on N. America troubles - Yahoo Finance UK
Porsche names new CFO and sales chief in bid to revive performance - Yahoo Finance UK
Aston Martin cuts 170 jobs as losses, debt balloon - Yahoo Finance UK
M&A News: Eli Lilly (LLY) Expands IBD Pipeline with Organovo’s FXR Program - TipRanks
This Biotech Stock Ripped Following Program Acquisition Announcement - The Globe and Mail
Why Eli Lilly Stock Popped Today - sharewise
Organovo Offloads FXR Agonist Portfolio To Lilly - Scrip
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com India
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com UK
Dow Surges 200 Points; Keurig Dr Pepper Posts Upbeat Earnings - Benzinga
Biotech Stock Organovo Holdings (Nasdaq: ONVO) Soars on Eli Lilly (NYSE: LLY) Deal - Investorideas.com newswire
Organovo up 270% on FXR program deal with Lilly - The Pharma Letter
This craft chain is closing nationwide, including in Grand Junction - Yahoo News
Top Midday Gainers -February 25, 2025 at 01:48 pm EST - Marketscreener.com
Nasdaq Dips 1.5%; Home Depot Issues Weak Forecast - Benzinga
Organovo’s FXR program to be acquired by Eli Lilly - MSN
Trinidad and Tobago to seek US licence extension for Dragon gas project in Venezuela - Yahoo
Cairn Oil & Gas commits $5.7bn to oil and gas exploration in Assam, India - Yahoo
Finders and Dnotitia partner to apply AI in insurance data analysis - Yahoo
Blue Cloud Softech Solutions secures Pinnacle Hospitals OMS project - Yahoo
Exclusive-Head of Fed-watchdog task force in Congress plans broad U.S. central bank review - Yahoo
Safe Harbor Marinas, owner of multiple RI boatyards, sold to Blackstone private equity - Yahoo News
Greenland Resources secures molybdenum supply deal with Outokumpu - Yahoo
Stock market today: China SXT Pharmaceuticals plunged by 92.61% while Wah Fu Education Group surged by 239.75% in early trading - Business Upturn
Why Organovo (ONVO) Stock Is Skyrocketing - Benzinga
Organovo'S FXR Program, Including FXR314, To Be Acquired By Eli Lilly And Company - Marketscreener.com
Eli Lilly, Krispy Kreme, PayPal - TradingView
Eli Lilly acquires Organovo’s FXR program for IBD treatment By Investing.com - Investing.com South Africa
Eli Lilly to Acquire Organovo's FXR Program -February 25, 2025 at 08:54 am EST - Marketscreener.com
Eli Lilly acquires Organovo's FXR program for IBD treatment - Investing.com India
Eli Lilly stock rises after deal with Organovo (ONVO:NASDAQ) - Seeking Alpha
Eli Lilly acquires Organovo’s FXR program for IBD treatment - Investing.com
Organovo’s FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company - TradingView
Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients - Quantisnow
FTT Briefly Spikes After Sam Bankman-Fried Tweets for First Time in 2 Years - Yahoo Finance UK
3D Printing Medical Devices Market Analysis and Forecast to 2033: Market Opportunities, Trends, and Pricing Analysis - openPR
UK regulator accepts Gatwick Airport commitments - Yahoo Finance UK
Volkswagen, CATL to collaborate in China on lithium battery development - Yahoo Finance UK
Organovo Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Organovo: Fiscal Q3 Earnings Snapshot - CT Insider
Organovo: Fiscal Q3 Earnings Snapshot -February 19, 2025 at 09:18 am EST - Marketscreener.com
ORGANOVO HOLDINGS, INC. SEC 10-Q Report - TradingView
3.91%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):